Dr. Venkatesh, currently serving as Managing Director at Noah Therapeutics, is a distinguished figure in the field of clinical research, boasting over two decades of extensive experience. His academic journey is marked by a Master’s and PhD in Clinical Research, underpinning his profound understanding of pharmaceutical sciences and therapeutic interventions.
Throughout his career, Dr. Venkatesh has spearheaded more than 1000 clinical trials, spanning Bioequivalence/Bioavailability (BA/BE) studies and Clinical Phase Trials across diverse therapeutic areas and dosage forms. His expertise extends to navigating the stringent regulatory frameworks of leading global agencies such as the US FDA, EMA, WHO, ANVISA, and UK MHRA, reflecting his adeptness in ensuring compliance and quality standards.
Dr. Venkatesh’s leadership acumen has been honed through various pivotal roles, from serving as a Principal Investigator to founding a Contract Research Organization (CRO). His professional journey commenced at GVK Bio, where he garnered essential insights into managing research enterprises. Subsequently, he co-founded Clinsync, leveraging his entrepreneurial spirit to establish impactful CROs in regions like China (Auwekare, subsidiary of Bostal and Austar Pharma) and Tunisia (Clinical CRO).
Beyond his professional achievements, Dr. Venkatesh has been recognized for his contributions to public health initiatives. Notably, he received a Certificate of Appreciation from the Guinness Book of World Records for his role in organizing the largest event on Oral Hygiene, involving 4,578 participants, in collaboration with Dr. Ramkishan Naik.
Dr. Venkatesh continues to drive innovation and excellence in clinical research, embodying a commitment to advancing healthcare through rigorous scientific inquiry and strategic leadership. His steadfast dedication and profound impact underscore his position as a trailblazer in the pharmaceutical and CRO sectors.
